These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17563255)

  • 1. Antibodies against RAGE in sepsis and inflammation: implications for therapy.
    Lutterloh EC; Opal SM
    Expert Opin Pharmacother; 2007 Jun; 8(9):1193-6. PubMed ID: 17563255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.
    Lutterloh EC; Opal SM; Pittman DD; Keith JC; Tan XY; Clancy BM; Palmer H; Milarski K; Sun Y; Palardy JE; Parejo NA; Kessimian N
    Crit Care; 2007; 11(6):R122. PubMed ID: 18042296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?
    Christaki E; Lazaridis N; Opal SM
    Curr Opin Infect Dis; 2012 Jun; 25(3):304-11. PubMed ID: 22327468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effect of anti-HMGB1 antibody and anti-RAGE antibody on SIRS/sepsis].
    Unoshima M
    Nihon Rinsho; 2004 Dec; 62(12):2323-9. PubMed ID: 15597804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia.
    Christaki E; Opal SM; Keith JC; Kessimian N; Palardy JE; Parejo NA; Tan XY; Piche-Nicholas N; Tchistiakova L; Vlasuk GP; Shields KM; Feldman JL; Lavallie ER; Arai M; Mounts W; Pittman DD
    Shock; 2011 May; 35(5):492-8. PubMed ID: 21263385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac RAGE in sepsis: call TOLL free for anti-RAGE.
    Feuerstein GZ
    Circ Res; 2008 May; 102(10):1153-4. PubMed ID: 18497315
    [No Abstract]   [Full Text] [Related]  

  • 7. AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.
    Nienhuis HL; Westra J; Smit AJ; Limburg PC; Kallenberg CG; Bijl M
    Autoimmunity; 2009 May; 42(4):302-4. PubMed ID: 19811283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.
    van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T
    J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of receptor for advanced glycation endproducts (RAGE) in infection.
    van Zoelen MA; Achouiti A; van der Poll T
    Crit Care; 2011; 15(2):208. PubMed ID: 21457506
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.
    Liliensiek B; Weigand MA; Bierhaus A; Nicklas W; Kasper M; Hofer S; Plachky J; Gröne HJ; Kurschus FC; Schmidt AM; Yan SD; Martin E; Schleicher E; Stern DM; Hämmerling G Gü; Nawroth PP; Arnold B
    J Clin Invest; 2004 Jun; 113(11):1641-50. PubMed ID: 15173891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 as a late mediator of lethal systemic inflammation.
    Wang H; Yang H; Czura CJ; Sama AE; Tracey KJ
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1768-73. PubMed ID: 11734424
    [No Abstract]   [Full Text] [Related]  

  • 13. Inciting inflammation: the RAGE about tumor promotion.
    Dougan M; Dranoff G
    J Exp Med; 2008 Feb; 205(2):267-70. PubMed ID: 18268042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?
    Lorenzi R; Grossin N; Lambert M; Daroux M; Adjoutah Z; Flahaut C; Jacolot P; Tessier FJ; Lefranc D; Desremaux P; Dubucquoi S; Boulanger E
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):248-57. PubMed ID: 23982266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting RAGE in sepsis.
    van Zoelen MA; van der Poll T
    Crit Care; 2008; 12(1):103. PubMed ID: 18254937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.
    Schmidt AM; Stern DM
    Front Biosci; 2001 Oct; 6():D1151-60. PubMed ID: 11578972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting RAGE Signaling in Inflammatory Disease.
    Hudson BI; Lippman ME
    Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases.
    Eichhorst A; Daniel C; Rzepka R; Sehnert B; Nimmerjahn F; Voll RE; Chevalier N
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31266174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.
    Iannitti RG; Casagrande A; De Luca A; Cunha C; Sorci G; Riuzzi F; Borghi M; Galosi C; Massi-Benedetti C; Oury TD; Cariani L; Russo M; Porcaro L; Colombo C; Majo F; Lucidi V; Fiscarelli E; Ricciotti G; Lass-Flörl C; Ratclif L; Esposito A; De Benedictis FM; Donato R; Carvalho A; Romani L
    Am J Respir Crit Care Med; 2013 Dec; 188(11):1338-50. PubMed ID: 24127697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.